Highland Capital Management (Tennessee)’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Highland Capital Management (Tennessee)’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-4,100	Closed	-$26K	–	349
2016 Q3	$26K	Hold	4,100	–	–	﹤0.01%	328
2016 Q2	$18K	Buy	4,100 +2,500	+156%	+$16.3K	﹤0.01%	327
2016 Q1	$17K	Buy	+1,600	New	+$31.8K	﹤0.01%	303
2015 Q4	–	Sell	-2,600	Closed	-$82K	–	641
2015 Q3	$82K	Buy	2,600 +500	+24%	+$23.9K	0.01%	340
2015 Q2	$124K	Buy	2,100 +1,000	+91%	+$70.5K	0.01%	331
2015 Q1	$118K	Buy	+1,100	New	+$105K	0.02%	144

Other funds holding PTX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Globeflex Capital San Diego, California $783M AUM 81.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Highland Capital Management (Tennessee)'s PTX Position: Q4 2016 in Review

Highland Capital Management (Tennessee) sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q4 2016, closing a stake of 4,100 shares — an estimated $26K sold.

Highland Capital Management (Tennessee) first reported a position in PTX in Q1 2015 and held it in 6 quarters. The position peaked at $124K in Q2 2015. 34 funds tracked by Wall St. Rank hold PTX as of Q4 2016.

Highland Capital Management (Tennessee) reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q4 2016 after selling out during the quarter.
Highland Capital Management (Tennessee) sold 4,100 Pernix Therapeutics Holdings, Inc. shares in Q4 2016, an estimated $26K.
Highland Capital Management (Tennessee) first reported a position in Pernix Therapeutics Holdings, Inc. in Q1 2015 and held it in 6 quarters.
Highland Capital Management (Tennessee)'s Pernix Therapeutics Holdings, Inc. position peaked at $124K in Q2 2015.
34 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q4 2016.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q4 2016, filed 20 Jan 2017.